Format
Sort by
Items per page

Send to

Choose Destination

Best matches for parkinson's:

Parkinson's disease and the skin. Gregory R et al. Pract Neurol. (2015)

Be vigilant for dementia in Parkinson’s disease. Niccolini F et al. Practitioner. (2017)

Cognition in Parkinson's Disease. O'Callaghan C et al. Int Rev Neurobiol. (2017)

Search results

Items: 1 to 20 of 103496

1.

In vivo visualization of age-related differences in the locus coeruleus.

Liu KY, Acosta-Cabronero J, Cardenas-Blanco A, Loane C, Berry AJ, Betts MJ, Kievit RA, Henson RN, Düzel E; Cam-CAN, Howard R, Hämmerer D.

Neurobiol Aging. 2018 Oct 20;74:101-111. doi: 10.1016/j.neurobiolaging.2018.10.014. [Epub ahead of print]

PMID:
30447418
2.

Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Zarriello S, Tuazon J, Corey S, Schimmel S, Rajani M, Gorsky A, Incontri D, Hammock BD, Borlongan CV.

Prog Neurobiol. 2018 Nov 14. pii: S0301-0082(18)30125-4. doi: 10.1016/j.pneurobio.2018.11.001. [Epub ahead of print] Review.

PMID:
30447256
3.

The Prodromes of Parkinson's disease.

Rees RN, Noyce AJ, Schrag A.

Eur J Neurosci. 2018 Nov 17. doi: 10.1111/ejn.14269. [Epub ahead of print]

PMID:
30447019
4.

Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG.

Cell Mol Neurobiol. 2018 Nov 16. doi: 10.1007/s10571-018-0632-3. [Epub ahead of print] Review.

PMID:
30446950
5.

Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Bartoletti-Stella A, Corrado P, Mometto N, Baiardi S, Durrenberger PF, Arzberger T, Reynolds R, Kretzschmar H, Capellari S, Parchi P.

Mol Neurobiol. 2018 Nov 16. doi: 10.1007/s12035-018-1421-1. [Epub ahead of print]

PMID:
30446946
6.

A hPSC-based platform to discover gene-environment interactions that impact human β-cell and dopamine neuron survival.

Zhou T, Kim TW, Chong CN, Tan L, Amin S, Sadat Badieyan Z, Mukherjee S, Ghazizadeh Z, Zeng H, Guo M, Crespo M, Zhang T, Kenyon R, Robinson CL, Apostolou E, Wang H, Xiang JZ, Evans T, Studer L, Chen S.

Nat Commun. 2018 Nov 16;9(1):4815. doi: 10.1038/s41467-018-07201-1.

PMID:
30446643
7.

Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers parkin activation.

Condos TE, Dunkerley KM, Freeman EA, Barber KR, Aguirre JD, Chaugule VK, Xiao Y, Konermann L, Walden H, Shaw GS.

EMBO J. 2018 Nov 16. pii: e100014. doi: 10.15252/embj.2018100014. [Epub ahead of print]

PMID:
30446597
8.

Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients.

Xu SS, Alexander PK, Lie Y, Dore V, Bozinovski S, Mulligan RS, Young K, Villemagne VL, Rowe CC.

BMJ Open. 2018 Nov 15;8(11):e025533. doi: 10.1136/bmjopen-2018-025533.

PMID:
30446576
9.

Individual differences in dopamine are associated with reward discounting in clinical groups but not in healthy adults.

Castrellon JJ, Seaman KL, Crawford JL, Young JS, Smith CT, Dang LC, Hsu M, Cowan RL, Zald DH, Samanez-Larkin GR.

J Neurosci. 2018 Nov 16. pii: 1984-18. doi: 10.1523/JNEUROSCI.1984-18.2018. [Epub ahead of print]

PMID:
30446530
10.

Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease.

Contin M, Lopane G, Mohamed S, Calandra-Buonaura G, Capellari S, De Massis P, Nassetti S, Perrone A, Riva R, Sambati L, Scaglione C, Cortelli P.

Parkinsonism Relat Disord. 2018 Nov 8. pii: S1353-8020(18)30488-7. doi: 10.1016/j.parkreldis.2018.11.007. [Epub ahead of print]

PMID:
30446407
11.

Charcot spinal arthropathy presenting as adjacent segment disease after lumbar spinal fusion surgery in Parkinson's disease: A case report.

Miura K, Koda M, Tatsumura M, Shiina I, Mammoto T, Hirano A, Abe T, Funayama T, Noguchi H, Yamazaki M.

J Clin Neurosci. 2018 Nov 13. pii: S0967-5868(18)31165-2. doi: 10.1016/j.jocn.2018.11.013. [Epub ahead of print]

PMID:
30446371
12.

Impact of major earthquakes on Parkinson's disease.

Kurisaki R, Ueyama H, Maeda Y, Sakamoto T, Nakahara K, Nakane S, Yamashita S, Ando Y; 2016 Kumamoto Earthquake PD Study Group.

J Clin Neurosci. 2018 Nov 13. pii: S0967-5868(18)31136-6. doi: 10.1016/j.jocn.2018.10.107. [Epub ahead of print]

PMID:
30446368
13.

In Vitro and In Silico Analyses of Nicotine Release from a Gelisphere-Loaded Compressed Polymeric Matrix for Potential Parkinson's Disease Interventions.

Kumar P, Choonara YE, du Toit LC, Singh N, Pillay V.

Pharmaceutics. 2018 Nov 15;10(4). pii: E233. doi: 10.3390/pharmaceutics10040233.

PMID:
30445765
14.

In Reply: Deep Brain Stimulation of the Pedunculopontine Nucleus Area in Parkinson Disease: Magnetic Resonance Imaging-Based Anatomoclinical Correlations and Optimal Target.

Goetz L, Chabardès S.

Neurosurgery. 2018 Nov 16. doi: 10.1093/neuros/nyy518. [Epub ahead of print] No abstract available.

PMID:
30445622
15.

Identification of Somatotopic Organization and Optimal Stimulation Site Within the Subthalamic Nucleus for Parkinson's Disease.

Sasaki T, Kuwahara K, Kin I, Okazaki M, Sasada S, Shinko A, Kameda M, Yasuhara T, Agari T, Date I.

Oper Neurosurg (Hagerstown). 2018 Nov 16. doi: 10.1093/ons/opy351. [Epub ahead of print]

PMID:
30445556
16.

The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019.

Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, McMahon A, Morales J, Mountjoy E, Sollis E, Suveges D, Vrousgou O, Whetzel PL, Amode R, Guillen JA, Riat HS, Trevanion SJ, Hall P, Junkins H, Flicek P, Burdett T, Hindorff LA, Cunningham F, Parkinson H.

Nucleic Acids Res. 2018 Nov 16. doi: 10.1093/nar/gky1120. [Epub ahead of print]

PMID:
30445434
17.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Nov 16. doi: 10.1002/mds.27519. [Epub ahead of print]

PMID:
30444952
18.

Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.

Baumann A, Nebel A, Granert O, Giehl K, Wolff S, Schmidt W, Baasch C, Schmidt G, Witt K, Deuschl G, Hartwigsen G, Zeuner KE, van Eimeren T.

Neurorehabil Neural Repair. 2018 Nov 16:1545968318812726. doi: 10.1177/1545968318812726. [Epub ahead of print]

PMID:
30444176
19.

Effects of kinesiotherapy on muscle strengthening in patients with Parkinson disease.

Tanović E, Talić-Tanović A, Ðelilović-Vranić J, Rekić A, Papović A, Tanović E.

Med Glas (Zenica). 2019 Feb 1;16(1). doi: 10.17392/970-18. [Epub ahead of print]

PMID:
30444088
20.

White matter myelin profiles linked to clinical subtypes of Parkinson's disease.

Baumeister TR, Kim JL, Zhu M, McKeown MJ.

J Magn Reson Imaging. 2018 Nov 15. doi: 10.1002/jmri.26543. [Epub ahead of print]

PMID:
30444020

Supplemental Content

Loading ...
Support Center